Adoptive immunotherapy in human and canine chimeras--the role of interferon alfa. EBMT Chronic Leukemia Working Party.
Kolb
H J
HJ
Medizinische Klinik III, Klinikum Grosshadern, Universität München, Germany.
Mittermüller
J
J
Hertenstein
H
H
Schumm
M
M
Holler
E
E
de Witte
T
T
Günther
W
W
Ljungman
P
P
Goldman
J M
JM
D000208:Acute Disease; D000818:Animals; D002678:Chimera; D004285:Dogs; D005260:Female; D006086:Graft vs Host Disease / Q000150:complications / Q000628:therapy*; D006801:Humans; D016219:Immunotherapy, Adoptive; D016898:Interferon-alpha / Q000627:therapeutic use*; D007938:Leukemia / Q000150:complications / Q000628:therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000628:therapy; D017710:Lymphocyte Transfusion; D008223:Lymphoma / Q000150:complications / Q000628:therapy; D008297:Male; D009101:Multiple Myeloma / Q000150:complications / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000628:therapy; D055728:Primary Myelofibrosis / Q000150:complications / Q000628:therapy
D016898:Interferon-alpha